Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma

被引：47

作者：

Toh Y. ^{[1
]}

Egashira A. ^{[1
]}

Yamamoto M. ^{[1
]}

机构：

[1] Department of Gastroenterological Surgery, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku

来源：

General Thoracic and Cardiovascular Surgery | 2013年 / 61卷 / 5期

关键词：

Clinical implications; DNA methylation; Epigenetics; Esophageal squamous cell carcinoma; Histone modification; MicroRNA;

D O I：

10.1007/s11748-013-0235-3

中图分类号：

学科分类号：

摘要：

Alterations in the regulation of gene expression that do not involve a change in the DNA sequence have been increasingly recognized as an important key event of carcinogenesis, referred to as "epigenetic" changes. Major epigenetic mechanisms include the methylation of cytosines in DNA, changes of histone and chromatin structure by covalent posttranslational modifications of histone proteins and alterations in the expression of microRNAs. These epigenetic alterations have also been identified in esophageal squamous cell carcinoma (ESCC). In this brief review, we will discuss DNA hypermethylation of the tumor suppressor gene promoters, histone modifications including histone acetylation/deacetylation and histone methylation and microRNAs in ESCC. Clinical implications of these epigenetic alterations in ESCC will be also discussed. © 2013 The Japanese Association for Thoracic Surgery.

引用

页码：262 / 269

页数：7

共 61 条

[1]

Shibata, A., Matsuda, T., Ajiki, W., Sobue, T., Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001 (2008) Jpn J Clin Oncol, 38, pp. 464-468. , 18664481 10.1093/jjco/hyn064

[2]

Enzinger, P.C., Mayer, R.J., Esophageal cancer (2003) N Engl J Med, 349, pp. 2241-2252. , 14657432 10.1056/NEJMra035010 1:CAS:528:DC%2BD3sXps1WhsL8%3D

[3]

Holmes, R.S., Vaughan, T.L., Epidemiology and pathogenesis of esophageal cancer (2007) Semin Radiat Oncol, 17, pp. 2-9. , 17185192 10.1016/j.semradonc.2006.09.003

[4]

Toh, Y., Oki, E., Ohgaki, K., Sakamoto, Y., Ito, S., Egashira, A., Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: Molecular mechanisms of carcinogenesis (2010) Int J Clin Oncol, 15, pp. 135-144. , 20224883 10.1007/s10147-010-0057-6 1:CAS:528:DC%2BC3cXksFGms78%3D

[5]

Hanahan, D., Weinberg, R.A., Hallmarks of cancer: The next generation (2011) Cell, 144, pp. 646-674. , 21376230 10.1016/j.cell.2011.02.013 1:CAS:528:DC%2BC3MXjsFeqtrk%3D

[6]

You, J.S., Jones, P.A., Cancer genetics and epigenetics: Two sides of the same coin? (2012) Cancer Cell, 22, pp. 9-20. , 22789535 10.1016/j.ccr.2012.06.008 1:CAS:528:DC%2BC38XhtVSltb7K

[7]

Sawan, C., Vaissiere, T., Murr, R., Herceg, Z., Epigenetic drivers and genetic passengers on the road to cancer (2008) Mutat Res, 642, pp. 1-13. , 18471836 10.1016/j.mrfmmm.2008.03.002 1:CAS:528:DC%2BD1cXns1ahsrY%3D

[8]

Kelly, T.K., De Carvalho, D.D., Jones, P.A., Epigenetic modifications as therapeutic targets (2010) Nat Biotechnol, 28, pp. 1069-1078. , 20944599 10.1038/nbt.1678 1:CAS:528:DC%2BC3cXht1yjs7bJ

[9]

Miremadi, A., Oestergaard, M.Z., Pharoah, P.D., Caldas, C., Cancer genetics of epigenetic genes (2007) Hum Mol Genet, 16 (SPEC. NO 1), pp. 28-R49. , 17613546 10.1093/hmg/ddm021 1:CAS:528:DC%2BD2sXosFOhtLc%3D

[10]

Zhao, R., Casson, A.G., Epigenetic aberrations and targeted epigenetic therapy of esophageal cancer (2008) Curr Cancer Drug Targets, 8, pp. 509-521. , 18781897 10.2174/156800908785699306 1:CAS:528:DC%2BD1cXhtVGqu7%2FF

← 1 2 3 4 5 6 7 →